Hypercontractility and Oxidative Stress Drive Creatine Kinase Dysfunction in Hypertrophic Cardiomyopathy
Circulation · 2025
DOI: 10.1161/circulationaha.125.074120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, 2025. Verfasst von Anton Xu und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Science, University Clinic Würzburg, Würzburg, Germany (A.X., D.W., K.J.E., J.M.F., F.S., E.G., J.D., M.K., A.G.N., C.M.,…. Hauptthemen laut MEDLINE: Oxidative Stress, Cardiomyopathy, Hypertrophic, Myocytes, Cardiac, Creatine Kinase. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a prevalent inherited cardiac disorder marked by left ventricular hypertrophy and hypercontractility. This excessive mechanical workload creates an energetic mismatch in which consumption exceeds production, leading to myocardial energy depletion. Although CK (creatine kinase) plays a key role in cardiac energy homeostasis, its involvement in HCM remains unclear. This study investigates how hypercontractility-driven mitochondrial stress and the resulting increase in mitochondrial H 2 O 2 disrupt CK function in HCM. METHODS: CK function was analyzed using myocardial left ventricular tissue from 92 patients with HCM (with and without pathogenic sarcomere variants) and 30 non-failing human controls. Myofilament and mitochondrial CK isoforms were measured using mRNA analysis, protein immunoblotting, enzyme activity assays, mass spectrometry, and redox-sensitive proteomics. To explore links between hypercontractility, mitochondrial reactive oxygen species, and CK dysfunction, we used isolated cardiomyocytes from wild-type, mitochondrial-targeted catalase-overexpressing, CK knockout (myofilament and mitochondrial CK deletion), HCM-associated Mybpc3 knock-in, and mito-roGFP2-Orp1 mouse models. We also tested the effects of the Ca 2+ sensitizer EMD-57033, the CK inhibitor 1-fluoro-2,4-dinitrobenzene (DNFB), and the myosin inhibitor MYK-581, a mavacamten derivative. RESULTS: Our analysis revealed significant reductions in myofilament and mitochondrial CK protein levels, as well as CK activity, in myocardium of patients with HCM, primarily because of oxidative modifications of CK. In isolated mouse cardiomyocytes from wild-type and CK knockouts, hypercontractility induced by EMD-57033 elevated mitochondrial H 2 O 2 , causing cellular arrhythmias and CK inactivation. Hypercontractility-induced oxidative stress, arrhythmias, and CK dysfunction were also observed in Mybpc3 knock-in cardiomyocytes. Mitochondrial-targeted catalase-overexpressing mice with enhanced H 2 O 2 scavenging were protected against H 2 O 2 -induced (EMD-57033-mediated) arrhythmias and CK dysfunction. MYK-581 treatment in Mybpc3 knock-in cardiomyocytes reduced hypercontractility, lowered H 2 O 2 production and arrhythmias, and preserved CK function. CK inhibition using DNFB in wild-type cardiomyocytes elevated mitochondrial H 2 O 2 levels and triggered cellular arrhythmias. This mitochondrial oxidation was independently confirmed in mito-roGFP2-Orp1 cardiomyocytes exposed to DNFB. Mitochondrial-targeted catalase-overexpressing mice were protected from DNFB–induced oxidative stress and arrhythmogenic events. CONCLUSIONS: This study reveals a mechanistic link between hypercontractility, mitochondrial reactive oxygen species, and CK dysfunction in HCM, perpetuating a cycle of energetic dysfunction. Targeting hypercontractility and oxidative stress through myosin inhibition offers a strategy to restore energy balance and reduce arrhythmic risk in HCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Science, University Clinic Würzburg, Würzburg, Germany (A.X., D.W., K.J.E., J.M.F., F.S., E.G., J.D., M.K., A.G.N., C.M., V.S.).
- Department of Internal Medicine, University of Genova, Genova, Italy (E.B.).
- Faculty of Medicine, Institute for Legal Medicine (J.M.F.), Saarland University, Homburg (Saar), Germany.
- Division of Cardiology, Molecular and Experimental Cardiology and Institute of Physiology, Cellular and Translational Physiology, Ruhr University Bochum, Bochum, Germany (M.T., N.H.).
- Radcliffe Department of Medicine, University of Oxford, Oxford, UK (S.Z., C.A.L.).
- Department of Cardiac Physiology, National Cerebral and Cardiovascular Center Research Institute, Suita-shi, Osaka, Japan (M.T.W., J.T.P.).
ORCID-Profile: David Weissman, Edoardo Bertero, Jan M Federspiel, Sevasti Zervou, Mark T Waddingham, James T Pearson, Jan-Christian Reil, Smita Scholtz, Michael Kohlhaas, Alexander G Nickel, Lucie Carrier, Thomas Eschenhagen, Michelle Michels, Cris Dos Remedios, Sean Lal, Nazha Hamdani, Diederik W D Kuster, Inês Falcão-Pires, Christopher N Johnson, Jolanda van der Velden, Christoph Maack, Vasco Sequeira
Förderung
- NIGMS NIH HHS
Zitieren
APA
Xu, A., Weissman, D., Ermer, K. J., Bertero, E., Federspiel, J. M., Stadler, F., Grünler, E., Tangos, M., Zervou, S., Waddingham, M. T., Pearson, J. T., Reil, J. C., Scholtz, S., Dudek, J., Kohlhaas, M., Nickel, A. G., Carrier, L., Eschenhagen, T., Michels, M., …, & Sequeira, V. (2025). Hypercontractility and Oxidative Stress Drive Creatine Kinase Dysfunction in Hypertrophic Cardiomyopathy. Circulation. https://doi.org/10.1161/circulationaha.125.074120
Vancouver
Xu A, Weissman D, Ermer KJ, Bertero E, Federspiel JM, Stadler F, et al. Hypercontractility and Oxidative Stress Drive Creatine Kinase Dysfunction in Hypertrophic Cardiomyopathy. Circulation. 2025. doi:10.1161/circulationaha.125.074120
BibTeX
@article{Xu2025,
author = {Xu, Anton and Weissman, David and Ermer, Katharina J and Bertero, Edoardo and Federspiel, Jan M and Stadler, Felix and Grünler, Elisa and Tangos, Melina and Zervou, Sevasti and Waddingham, Mark T and Pearson, James T and Reil, Jan-Christian and Scholtz, Smita and Dudek, Jan and Kohlhaas, Michael and Nickel, Alexander G and Carrier, Lucie and Eschenhagen, Thomas and Michels, Michelle and Dos Remedios, Cris and Lal, Sean and Prates Roma, Leticia and Hamdani, Nazha and Kuster, Diederik W D and Falcão-Pires, Inês and Johnson, Christopher N and Lygate, Craig A and van der Velden, Jolanda and Maack, Christoph and Sequeira, Vasco},
title = {Hypercontractility and Oxidative Stress Drive Creatine Kinase Dysfunction in Hypertrophic Cardiomyopathy},
journal = {Circulation},
year = {2025},
doi = {10.1161/circulationaha.125.074120}
}
EUVIMED